Literature DB >> 10890675

Pyridoxine therapy in a patient with severe hydrazine sulfate toxicity.

R Nagappan1, T Riddell.   

Abstract

OBJECTIVE: To report hydrazine sulfate as a cause of severe encephalopathy and to report its response to high-dose pyridoxine therapy.
DESIGN: Case report.
SETTING: An adult six-bed medical/surgical intensive care unit of a general hospital. PATIENT: One patient who developed severe encephalopathy after hydrazine sulfate. INTERVENTION: 5 g i.v. pyridoxine.
MEASUREMENTS AND MAIN RESULTS: After 180 mg/day for 2 wks followed by 360 mg/day of hydrazine sulfate ingestion, our patient suffered severe encephalopathy. He received mechanical ventilation with attendant supportive measures and high-dose pyridoxine. The patient's encephalopathy resolved 24 hrs after receiving pyridoxine.
CONCLUSION: Severe encephalopathy could result from hydrazine sulfate toxicity. High-dose pyridoxine is an effective treatment to reverse this encephalopathy.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10890675     DOI: 10.1097/00003246-200006000-00076

Source DB:  PubMed          Journal:  Crit Care Med        ISSN: 0090-3493            Impact factor:   7.598


  1 in total

1.  Critical care medicine mailing list: growth of an online forum.

Authors:  Anthony L DeWitt; Scott R Gunn; Phil Hopkins; Stephen Streat
Journal:  BMJ       Date:  2004-05-15
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.